UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006838 |
|---|---|
| Receipt number | R000007281 |
| Scientific Title | Multicenter pahse II tiral of combination therapy using abraxane and trastuzumab +-pertuzumab for HER2-positive locally advanced or metastatic breast cancer |
| Date of disclosure of the study information | 2011/12/06 |
| Last modified on | 2020/03/15 13:37:22 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/12/05 15:01:19 | ||
| 2 | Update | 2013/12/05 09:32:01 | Interventions/Control_1 Interventions/Control_1 Key exclusion criteria Key exclusion criteria |
|
| 3 | Update | 2013/12/05 09:36:36 | Email TEL Organization Organization |
|
| 4 | Update | 2014/06/05 13:26:11 | Public title Public title Acronym Acronym |
|
| 5 | Update | 2014/06/05 13:27:24 | Narrative objectives1 Narrative objectives1 |
|
| 6 | Update | 2014/06/05 13:31:27 | Interventions/Control_1 Interventions/Control_1 |
|
| 7 | Update | 2016/06/09 17:01:58 | Name of primary person or sponsor Organization |
|
| 8 | Update | 2020/03/15 13:06:51 | Recruitment status Date of IRB Last follow-up date |
|
| 9 | Update | 2020/03/15 13:08:58 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 10 | Update | 2020/03/15 13:37:22 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
